Sorrento Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Sep 13, 2022 18:15 ET
Sorrento Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Jun 14, 2022 14:51 ET
Sorrento Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
May 23, 2022 09:06 ET
Sorrento Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Mar 18, 2022 09:03 ET
Sorrento Therapeutics | 424B7: Prospectus
Mar 3, 2022 17:08 ET
Sorrento Therapeutics | 424B5: Prospectus
Dec 3, 2021 16:33 ET
Sorrento Therapeutics | EFFECT: Others
Jul 16, 2021 00:15 ET
Sorrento Therapeutics | 424B3: Prospectus
Jul 15, 2021 17:01 ET
Sorrento Therapeutics | EFFECT: Others
Jun 2, 2021 00:15 ET
Sorrento Therapeutics | 424B3: Prospectus
Jun 1, 2021 16:59 ET
Sorrento Therapeutics | EFFECT: Others
Apr 20, 2021 00:15 ET
Sorrento Therapeutics | 424B3: Prospectus
Apr 19, 2021 19:20 ET
Sorrento Therapeutics | EFFECT: Others
Apr 6, 2021 00:15 ET
Sorrento Therapeutics | 424B3: Prospectus
Apr 5, 2021 18:41 ET
Sorrento Therapeutics | 424B5: Prospectus
Dec 4, 2020 17:15 ET
Sorrento Therapeutics | 424B3: Prospectus
Dec 4, 2020 17:05 ET
Sorrento Therapeutics | 424B3: Prospectus
Oct 21, 2020 16:16 ET
Sorrento Therapeutics | EFFECT: Others
Oct 21, 2020 00:15 ET
Sorrento Therapeutics | EFFECT: Others
Oct 9, 2020 00:15 ET
Sorrento Therapeutics | 424B3: Prospectus
Oct 8, 2020 17:22 ET
No Data
No Data